The comparison of pulmonary function and pain score in cervical epidural block

Not Applicable

Completed

• Conditions: Diseases of the musculoskeletal system and connective tissue

• Registration Number: KCT0004343
• Lead Sponsor: Ewha Womans University Medical Center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2020-08-31
• Last Update Posted: 2 May 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Patients who visited the Ewha Womans University Mokdong Hospital Pain Clinic, aged 19 to 70 years old, and diagnosed with cervical herniated nucleus pulposus and spinal stenosis due to questionnaire, neurological examination, and radiographic findings. The patients undergoing cervical interlaminar epidural steroid spinal injection.

Exclusion Criteria

Patients who have undergone cervical interlaminar epidural steroid spinal injection within 4 weeks prior to the procedure, taken oral steroids, anticoagulants, or drugs that affect lung function, ropivacaine or steroid hypersensitivity, cognitive dysfunction, lung function disorder, liver function disorder.
If the patient or guardian disagree with the study, they are also excluded from the study.

Study & Design

• Study Type: Interventional Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Forced expiratory volume in one second (FEV1), Forced vital capacity (FVC), Peak expiratory flow rate (PEFR);VAS score

Secondary Outcome Measures

Name	Time	Method
eck Disability Index (NDI)